SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-07-000838
Filing Date
2007-06-08
Accepted
2007-06-08 13:54:20
Documents
10
Period of Report
2007-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k2005.htm 6-K 17383
2 2005 MANAGEMENT INFORMATION CIRCULAR ex991.htm EX-99.1 436302
3 2005 NOTICE OF MEETING ex992.htm EX-99.2 10399
4 2005 FORM OF PROXY ex993.htm EX-99.3 1679
5 2005 CERTIFICATIONS ex994.htm EX-99.4 18933
6 PERFORMANCE CHART pc2005.jpg GRAPHIC 17477
7 FRONT PAGE PROXY CARD proxycard1.jpg GRAPHIC 149473
8 BACK PAGE PROXY CARD proxycard2.jpg GRAPHIC 106133
9 FORM 11 PAGE 1 addendum1.jpg GRAPHIC 219266
10 FORM 11 PAGE 2 addendum2.jpg GRAPHIC 123267
  Complete submission text file 0001279569-07-000838.txt   1335269
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 07909167
SIC: 2836 Biological Products, (No Diagnostic Substances)